Our Team

Dr Christian Dombrowski is Senior Vice President, Platform, at Averna Therapeutics and a distinguished research leader with over 20 years of scientific innovation across multiple modalities and platform development. He has played a key role in advancing the development of cutting-edge gene-editing technologies and brings extensive experience from both pharma and small biotech. Prior to Averna, he led the CRISPR platform at Intellia Therapeutics for nearly a decade.

He received a BSc in biochemistry, an MSc in molecular genetics, and a PhD in molecular and cell biology from Laval University.